| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 01/15/2003 | CN1390943A Refractor 6-phosphoglucose isomerase gene and its polypeptide coded by it and preparing process |
| 01/15/2003 | CN1390941A Refractory cytidylic acid kinase gene and its polypeptide coded by it and preparing process |
| 01/15/2003 | CN1390939A Rice plant with high accumulating capability to proline and production thereof |
| 01/15/2003 | CN1390933A Process for preparing fragilis Kluyveromyce cell lactase |
| 01/15/2003 | CN1098932C Method of synthesizing fluorescently labeled protein |
| 01/14/2003 | US6506893 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 01/14/2003 | US6506603 DNA reassembly after random fragmentation; mutagenesis cycles; denaturing, incubation, genetic engineering, screening |
| 01/14/2003 | US6506602 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 01/14/2003 | US6506598 Gene expression of tissue plasminogen activator in butyrate salt |
| 01/14/2003 | US6506593 Production of thermostable xyalnases useful for modifying plant biomass and for enzyme-aided bleaching of wood pulp |
| 01/14/2003 | US6506592 Hyperthermophilic alpha-glucosidase gene and its use |
| 01/14/2003 | US6506589 Useful mutations of bacterial alkaline protease |
| 01/14/2003 | US6506588 Lipolytic enzymes |
| 01/14/2003 | US6506587 Nucleotide sequences coding enzymatic polypeptide; for use as an antitumor a gents |
| 01/14/2003 | US6506586 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 01/14/2003 | US6506585 Polypeptides having haloperoxidase activity |
| 01/14/2003 | US6506578 Nucelotide encoding megakaryocytic protein tyrosine kinases |
| 01/14/2003 | US6506571 Human glutathione-S-transferase |
| 01/14/2003 | US6506566 Screening enzymatic polypeptides for use in detergents; obtain microorganism expressing polypeptides, incubate with detergent, expose to binding protein, separate bound complex, isolate and propagate genome coding enzymatic variant |
| 01/14/2003 | US6506560 Cloned DNA polymerases from Thermotoga and mutants thereof |
| 01/14/2003 | US6506557 Methods and compositions for identifying a protease |
| 01/14/2003 | US6506550 Inducing apoptosis in cancer cells; drug screening for thiamine-depleting agents |
| 01/14/2003 | US6506414 Homogenizing a tissue in a nondenaturing aqueous solvent to obtain particles; aqueous solvent extraction; separation of solid and liquid; fractionating and purifying; inhibitors of matrix metalloprotease and angiogenesis; antitumor agents |
| 01/14/2003 | US6506379 Intramuscular delivery of recombinant AAV |
| 01/14/2003 | CA2102595C Truncated forms of the hepatocyte growth factor (hgf) receptor |
| 01/14/2003 | CA2027355C Yeast promoter |
| 01/13/2003 | CA2827024A1 Carbonic anhydrase system and process for treating a co2-containing gas |
| 01/13/2003 | CA2393376A1 Assay methods |
| 01/13/2003 | CA2353183A1 Fractionation apparatus with low surface area grid above tray deck |
| 01/11/2003 | CA2388776A1 Gene coding for cyclodextrin glucanotransferase chiefly producing y-cyclodextrin and use thereof |
| 01/09/2003 | WO2003002736A2 A walk-through technique for in vitro recombination of polynucleotide sequences |
| 01/09/2003 | WO2003002735A2 Methods, vectors, cell lines and kits for selecting nucleic acids having a desired feature |
| 01/09/2003 | WO2003002733A2 Compositions for enhanced catalyzed reporter deposition |
| 01/09/2003 | WO2003002732A1 Citrate lyase poly peptides |
| 01/09/2003 | WO2003002731A1 A PROCESS FOR PURIFICATION OF RECOMBINANT PORPHOBILINOGEN DEAMINASE (rhPBGD) |
| 01/09/2003 | WO2003002730A2 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/09/2003 | WO2003002729A1 A crystallised catalytic domain of matrix metalloproteinase 9 (mmp9) and the use of its three dimensional structure to design mmp9 modulators |
| 01/09/2003 | WO2003002728A2 Prevention of retrogradation of starch |
| 01/09/2003 | WO2003002727A2 Hammerhead ribozyme specific for the stearoyl-acp desaturrase of different oleaginous plants |
| 01/09/2003 | WO2003002720A2 2150, a human protein kinase family member and uses therefor |
| 01/09/2003 | WO2003002719A2 Isoform of castor oleate hydroxylase |
| 01/09/2003 | WO2003002716A2 Polymer stabilized proteinases |
| 01/09/2003 | WO2003002714A2 Protein tyrosine phosphatase 2 gene disruptions, compositions and methods related thereto |
| 01/09/2003 | WO2003002711A2 A NOVEL GROUP OF α-AMYLASES AND A METHOD FOR IDENTIFICATION AND PRODUCTION OF NOVEL α-AMYLASES |
| 01/09/2003 | WO2003002127A1 Use of at least one glycoinhibitor substance |
| 01/09/2003 | WO2003002105A2 Use of tyrosine kinase inhibitors for treating bone loss |
| 01/09/2003 | WO2003002088A2 Use of an oil of the gourd family for inhibiting 5$g(a)-reductase activity |
| 01/09/2003 | WO2003002063A2 Structure-based drug design methods for identifying d-ala-d-ala ligase inhibitors as antibacterial drugs |
| 01/09/2003 | WO2003001983A2 Methods for diagnosing and treating a disease mediated by decreased mmp-2 function |
| 01/09/2003 | WO2003001908A1 Hspc150-like gene disruptions, compositions and methods related thereto |
| 01/09/2003 | WO2003001879A2 Methods and systems for identifying kinases, phosphatases and substrates thereof |
| 01/09/2003 | WO2002095035A8 Crystal structure of ketopantoate reductase and use thereof |
| 01/09/2003 | WO2002079223A9 Covalently reactive transition state analogs and methods of use thereof |
| 01/09/2003 | WO2002077009A3 Polypeptides having gamma-glutamyl transpeptidase activity and nucleic acids encoding same |
| 01/09/2003 | WO2002074796A3 Histidine phosphatase interacting protein with 240kd |
| 01/09/2003 | WO2002063014A3 Human tyrosine-specific protein phosphatase |
| 01/09/2003 | WO2002059111A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/09/2003 | WO2002048335A9 Metal resistant plants and use for phytoremediation |
| 01/09/2003 | WO2002046444A3 Double transposition methods for manipulating nucleic acids |
| 01/09/2003 | WO2002044320A3 Human elongase genes and uses thereof |
| 01/09/2003 | WO2002042437A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 01/09/2003 | WO2002038774A3 Bacterial phytases and method for producing same |
| 01/09/2003 | WO2002038743A3 Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp |
| 01/09/2003 | WO2002032953A3 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 01/09/2003 | WO2002031158A3 Feedback-resistant pyruvate carboxylase gene from corynebacterium |
| 01/09/2003 | WO2002028175A3 Transgenic mouse for targeted recombination mediated by modified cre-er |
| 01/09/2003 | WO2002026997A3 Dsp-16 dual-specificity phosphatase |
| 01/09/2003 | WO2002022779A3 High level expression of heterologous proteins |
| 01/09/2003 | WO2002014485A3 Kallikrein gene |
| 01/09/2003 | WO2002006461A3 Inhibitors of plant peptide deformylase for use as broad-spectrum herbicides and methods for identifying the same |
| 01/09/2003 | WO2002000696A3 Herbicide target genes and methods |
| 01/09/2003 | WO2002000017A3 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 01/09/2003 | WO2001098510A3 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
| 01/09/2003 | WO2001097828A3 Rhob as a suppressor of cancer cell growth and cell transformation |
| 01/09/2003 | WO2001092463A3 Method of rna cleavage |
| 01/09/2003 | WO2001079489A8 39228, a human alcohol dehydrogenase and uses therefor |
| 01/09/2003 | WO2001079480A9 Albumin fusion proteins |
| 01/09/2003 | WO2001066779A3 Arabitol or ribitol as positive selectable markers |
| 01/09/2003 | WO2001066764A9 16835, a human phospholipase c and uses thereof |
| 01/09/2003 | WO2001066759A9 26886, a novel carnitine acyltransferase family member and uses therefor |
| 01/09/2003 | WO2001057267A9 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 01/09/2003 | WO2001056532A9 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc) |
| 01/09/2003 | WO2001055411A9 Human sulfatases |
| 01/09/2003 | WO2001055336A9 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/09/2003 | WO2001055333A9 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 01/09/2003 | US20030009784 Expression of trehalose biosynthetic genes in plants |
| 01/09/2003 | US20030009782 Compositions and methods for fumonisin detoxification |
| 01/09/2003 | US20030009779 Transgenic mice containing ubiquitin enzyme gene disruptions |
| 01/09/2003 | US20030009776 Transgenic animal; for use as model in the treatment of cancer |
| 01/09/2003 | US20030009026 Insertion sequence element derived from ralstonia solanacearum |
| 01/09/2003 | US20030009021 Novel human proteases and polynucleotides encoding the same |
| 01/09/2003 | US20030009019 Novel telomerase |
| 01/09/2003 | US20030009017 For diagnosis and therapy of cancer or aberrant cellular proliferation and/or differentiation, immune disorders, heart disorders, cardiovascular disorders, including endothelial cell disorders, hematopoietic and blood vessel disorder |
| 01/09/2003 | US20030009013 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009012 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030009011 Novel inositol polyphosphate kinase genes and uses thereof |
| 01/09/2003 | US20030009010 As vaccines for therapy and prophylaxis of Haemophilus influenzae infection |
| 01/09/2003 | US20030008866 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 01/09/2003 | US20030008836 Eukaryotic gene expression cassette and uses thereof |
| 01/09/2003 | US20030008819 Targeting endothelium for tissue-specific delivery of agents |